Inventaire - your friends and communities are your best library

A roadmap to the brittle bones of cystic fibrosis

published in: Journal of Osteoporosis

date of publication: 2010-12-16

main subject: cystic fibrosis

Cites articles 113

Date

Title

Authors

2011-01

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
2011-02-01

Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect

Michael McClung, Ian Reid, John A Eisman
2010-05

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
2010-01-28

Vitamin d deficiency in cystic fibrosis
2010-05-01

Prevalence of bone loss in a population with cystic fibrosis
2010-05-01

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density

Michael McClung, John A Eisman
2009-12-01

The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis
2009-08-20

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Michael McClung, Ian Reid, Silvano Adami, Richard Eastell
2009-07-17

Update on cystic fibrosis-related bone disease: a special focus on children

Isabelle Sermet-Gaudelus
2009-01-01

Potential new drug targets for osteoporosis
2009-04

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis
2009-12-14

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone

Frédéric Velard, Lhousseine Touqui
2009-09-23

Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis).

Mary L. Bouxsein
2009-08-01

Managing complications following lung transplantation
2008-07-18

Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).
2008-07-01

Hyperinflammation in airways of cystic fibrosis patients: what's new?

Olivier Tabary
2008-06-24

A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre
2008-05-27

DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation
2008-05-06

A soluble activin type IIA receptor induces bone formation and improves skeletal integrity

Ernesto Canalis, Mary L. Bouxsein
2008-04-02

Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercise for bone health in children with cystic fibrosis

Karen Hind
2008-09-24

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
2008-11-01

Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers

Caren M. Gundberg
2008-05-29

Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis

Caren M. Gundberg
2008-06-01

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
2008-05-01

RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats
2008-02-21

Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis

Adam Jaffe
2007-01-01

The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics
2007-07-01

Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone
2007-04-06

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
2007-03-29

In vivo analysis of Wnt signaling in bone

Donald Glass
2007-03-29

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton
2007-11-15

Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice

Article - wd:Q34442832

Welcome to Inventaire

the library of your friends and communities

learn more